Cardio Diagnostics Holdings, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $5.9M
- Price
- $2.00
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.91%
- Volume
- 22.1K
About
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Quick stats
Shares outstanding3.0M
Computed float2.8M
Float / shares95.8%
Cash runway (months)8.2
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001870144
Websitehttps://www.cdio.ai
AI Summary
AI-generated1/16
minorneutralother
Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges
Cardio Diagnostics released an updated report titled 'The State of Rural Hospitals and Cardiovascular Care,' analyzing workforce shortages and access barriers in rural healthcare.
The document highlights that 46% of U.S. counties lack practicing cardiologists and 28% of rural Americans lack broadband access, limiting telehealth options.
It proposes a four-part model for care delivery, emphasizing the company's AI-driven genetic and epigenetic testing to improve early detection and personalized care in underserved areas.